On Monday, Shares of Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI), gained 2.74% to $6.
Spectrum Pharmaceuticals, declared it will host a teleconference and webcast with administration to talk about the first quarter 2015 financial results, provide an update on the Company’s business, and talk about expectations for the future.
The conference call will be on Thursday, May 7, 2015 @ 4:30 p.m. Eastern/1:30 p.m. Pacific Time.
Spectrum Pharmaceuticals, Inc., a biotechnology company, develops and commercializes oncology and hematology drug products. The company markets five drug products, counting FUSILEV for the treatment of patients with metastatic colorectal cancer, rescue after high-dose methotrexate therapy in osteosarcoma, and to diminish the toxicity and counteract the effects of impaired methotrexate elimination and of inadvertent overdosage of folic acid antagonists.
At the end of Monday’s trade, Shares of Accuray Incorporated (NASDAQ:ARAY), jumped 2.71% to $7.
Accuray Incorporated, declared that it has signed a contract with MIM Software Inc. to further develop adaptive therapy software for the TomoTherapy® and CyberKnife® product portfolios. The new software solution will leverage both Accuray and MIM technology. This is Accuray’s second partnership with MIM; the previous partnership led to the development of the first iPad-based treatment plan review capability, PlanTouch™.
MIM Software Inc. is a respected vendor of software for the radiation oncology, radiology, and nuclear medicine markets. Since its inception in 2001, the company has made a commitment to advancing the healthcare field. MIM prides itself on its record of major innovations that have advanced the company’s primary aim of enhancing patient care, counting the development of automated adaptive therapy software. The software allows a sophisticated analysis based upon pre-treatment imaging that enables the clinician to determine whether changes in the patient’s anatomy over the course of therapy could reduce the effectiveness of the treatment. In the case of noteworthy changes, the treatment plan would be modified to account for the changes, and this would result in reduced dose to organs at risk and/or optimized dose delivered to the disease, which could, potentially, improve outcomes for patients.
Accuray Incorporated designs, develops, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body. The company offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body.
Novadaq Technologies Inc. (NASDAQ:NVDQ), ended its last trade with 2.56% gain, and closed at $10.82.
Novadaq Technologies, declared that administration will take part in four investor conferences in May.
- NOVADAQ is planned to present on Thursday, May 14th at 11:20 am Pacific Time at the Encore at the Wynn hotel in Las Vegas, NV.
- NOVADAQ is planned to present on May 19th at 3:00 pm Eastern Time at the Sheraton New York Times Square hotel in New York, NY.
Novadaq Technologies Inc. develops, manufactures, and markets fluorescence imaging products and therapeutic devices for use by surgeons in the operating room and other clinical settings in the United States and internationally.
Finally, Taubman Centers, Inc. (NYSE:TCO), closed at $75.24, with 2.52% gain.
Taubman Centers, stated financial results for the first quarter of 2015.
Operating Statistics
For the quarter, comparable center NOI not taking into account lease cancellation income was up 3.7 percent. Counting lease cancellation income, comparable center NOI growth was 5.3 percent. Average rent per square foot for the quarter was $60.12, up 4.2 percent from $57.71 in the comparable period last year. Trailing 12-month releasing spreads per square foot for the period ended March 31, 2015 were 31.8 percent.
Mall tenant sales per square foot were up 2.3 percent from the first quarter of 2014. This brings the company’s 12-month trailing mall tenant sales per square foot to $813, an enhance of 0.5 percent from the 12-months ended March 31, 2014. “We were happy to see that sales trended modestly up for the quarter, especially in an environment with virtually no inflation,” said Mr. Taubman.
Ending occupancy in comparable centers was 92.7 percent on March 31, 2015, down 0.4 percent from 93.1 percent on March 31, 2014. Leased space in comparable centers was 95.5 percent on March 31, 2015, down 0.5 percent from 96 percent on March 31, 2014.
Taubman Centers, Inc. operates as a real estate investment trust. As of June 30, 2005, the company owned a 63% managing general partner’s interest in The Taubman Realty Group Limited Partnership (the operating partnership).
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
